Results 51 to 60 of about 289,079 (118)

c-Myc: an emerging participant in heart failure. [PDF]

Front Cardiovasc Med
Wu Y, Zhang J, Liu R, Lin W, Wang W, Zhao Y, Cai Y, Su H, Sun W, Zhu H, Zhao M, Chang P.   +11 more
europepmc   +1 more source

Conformational reprogramming of c-Myc <i>via</i> intracellular cyclisation. [PDF]

RSC Chem Biol
Johnson RA, Mason JM.
europepmc   +1 more source

Pinoresinol as a Potential c-Myc Complex Modulator: An In Silico Study. [PDF]

Curr Issues Mol Biol
Villanueva-Castillo A, Mancilla-Simbro C, Villa-Diaz F, Ramírez-Mata A, Pastelín-Rojas CF, Moreno-Mejía RS, Lucio-Castillo H, Castro-Bautista BL, Castillo-Sosa CG, Matamoros-González F, Cruz-Espinosa A, Abascal-Grajales A, Olea-Amezcua MA, Castillo EB, Hernández-Aragón LG, Noriega AE, Reyes Carmona SR, Quintana FU, Lobato Huerta S.   +18 more
europepmc   +1 more source

Crotonylation impedes c-Myc oncogenic activity. [PDF]

Proc Natl Acad Sci U S A
Wallbillich NJ, Liao P, Srivastava R, Fan J, Zeng SX, Lu H.   +5 more
europepmc   +1 more source

Triggering SORL1 Expression Restricts ccRCC Progression by Inducing Ubiquitination-Mediated c-Myc Degradation. [PDF]

Cancer Sci
Wang K, Song W, Bai Q, Shen S, Lu X, Su C, Yang S, Wang Y, Xia Y, Zan R, Jiang S, Guo J.   +11 more
europepmc   +1 more source

Photoproximity labeling of c-Myc reveals SLK as a cancer-specific co-regulator. [PDF]

Nat Chem Biol
Milione RR, Tong F, Wolfe KL, Douglas CJ, Linker SB, Mu XJ, Oakley JV, Nager AR, Janiszewska M, Seath CP.   +9 more
europepmc   +1 more source

P38α deficiency alleviates myocardial ischemia/reperfusion injury by stabilizing c‑Myc to inhibit ferroptosis. [PDF]

Basic Res Cardiol
Ouyang X, Song S, Dong Y, Xiang M, Yin L, Wang X, Ma Y, Lu Y, Qi Y, Nong Q, Chen H, Yu R, Sarapultsev A, Cheng X, Luo S, Hu D.   +15 more
europepmc   +1 more source

The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma. [PDF]

Int J Mol Sci
Yue C, Huang BH, Qi L, Zhang XD, Li J.
europepmc   +1 more source

Targeted degradation of c-Myc through the midnolin-proteasome pathway. [PDF]

Proc Natl Acad Sci U S A
Zhao J, Wu H, Yu H, Li C, Mao Y, Yuan H, Li S.   +6 more
europepmc   +1 more source

Evaluation of c-Myc in odontogenic cysts and tumours-An immunohistochemical study. [PDF]

J Oral Maxillofac Pathol
Pinisetti S, Vinaya NL, Adusumilli P, Babburi S, Venigalla A, Benarjee A.   +5 more
europepmc   +1 more source